Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Accenture’s 300-page SEC disclosures can bury the datapoints that move the stock—cloud revenue mix, new bookings, and how many consultants billable hours really grew. Finding those nuggets across a dense 10-K, multiple 10-Q updates, and rapid-fire 8-K acquisitions is the challenge every ACN investor faces.
Stock Titan solves that problem by marrying real-time EDGAR feeds with AI-powered summaries that translate complex language into clear takeaways. Need the next Accenture quarterly earnings report 10-Q filing? It lands here seconds after the SEC posts it, alongside a plain-English breakdown of segment margins and headcount trends. Curious about Accenture insider trading Form 4 transactions? Our dashboard flags executive buys and sells the moment they’re filed, complete with historical context.
Explore every disclosure type in one place:
- Annual report 10-K—see how consulting versus managed-services revenue shifts, with Accenture annual report 10-K simplified by AI.
- Quarterly 10-Q—track bookings momentum and free-cash-flow swings.
- 8-K material events—instant reads on acquisitions, leadership changes, or dividend announcements: Accenture 8-K material events explained.
- Proxy statement—understand Accenture proxy statement executive compensation without sifting through tables.
- Form 4—monitor Accenture executive stock transactions Form 4 in real time.
Whether you’re modeling cash flow, comparing segment profitability, or watching Accenture Form 4 insider transactions real-time, Stock Titan delivers the data and plain-language insight you need—no PDF spelunking required.
Accenture plc (ACN) reported an insider transaction by officer Atsushi Egawa (Co-CEO Asia Pacific). On 11/01/2025, an immediate family member purchased 8 Class A ordinary shares at $212.0495 per share under the Amended and Restated Accenture plc 2010 Employee Share Purchase Plan. The transaction is reported as indirectly owned by the officer.
Following the transaction, indirect beneficial ownership stands at 56 shares, and direct beneficial ownership is 14,846 shares. This filing records a small, plan-based purchase and updates the officer’s reported holdings.
Accenture plc (ACN) reported an insider transaction by Chief Leadership & HR Officer Katherine Lee Clifford. On 11/01/2025, an immediate family member employed by Accenture acquired 27 Class A ordinary shares at $212.0495 per share under the Amended and Restated Accenture plc 2010 Employee Share Purchase Plan. Following the transaction, beneficial ownership includes 4,821 Class A ordinary shares held directly and 27 shares held indirectly by an immediate family member.
Accenture plc (ACN): Chair and CEO Julie Sweet reported open‑market sales of Class A ordinary shares on 10/29/2025 pursuant to a Rule 10b5‑1 trading plan. She sold 1,329 shares at a weighted average price of $252.0463, 3,806 shares at $252.9175, 2,104 shares at $253.9157, and 1,761 shares at $254.8409, each executed in multiple trades within stated price ranges.
Following these transactions, her beneficial ownership was 22,187 shares after the first sale, 18,381 after the second, 16,277 after the third, and 14,516 after the fourth. Prices reflect weighted averages; detailed trade breakdowns are available upon request as noted in the filing.
Accenture plc (ACN) received a Rule 144 notice for a proposed sale of 9,000 Class A ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of $2,278,350.00 and an approximate sale date of 10/29/2025.
The shares to be sold were acquired on 10/20/2025 via a stock award from the issuer in the same 9,000-share amount. As context, the filing lists 658,171,748 shares outstanding. The past three months section shows a sale by Julie Sweet of 9,000 Class A ordinary shares on 10/22/2025 for $2,246,165.10 in gross proceeds.
Accenture plc (ACN): Insider transaction filed. Ryoji Sekido, Co‑CEO Asia Pacific, reported open‑market sales totaling 2,500 Class A ordinary shares on 10/22/2025 pursuant to a Rule 10b5‑1 trading plan.
The sales were executed in three tranches: 494 shares at a weighted average price of $248.3699 (range $247.86–$248.65), 1,484 shares at $249.5688 (range $249.04–$249.96), and 522 shares at $250.2294 (range $250.07–$250.60). Following these transactions, the reporting person directly beneficially owns 1,390 shares.
Accenture plc (ACN) reported insider transactions by Chair and CEO Julie Sweet. On 10/22/2025, she sold 9,000 Class A ordinary shares in multiple tranches under a Rule 10b5-1 trading plan. Sales were executed at weighted average prices of $248.2045, $249.4098, $250.1299, and $250.869, with underlying trades spanning $247.82 to $250.98. Following these transactions, she beneficially owned 23,516 shares.
Accenture plc reported an insider transaction by its Chief Strategy & Services Officer, who sold 6,902 Class A ordinary shares on 10/22/2025. The sale was executed under a Rule 10b5-1 Trading Plan, indicating a pre-arranged, automated program. The weighted average sale price was $250.0068, with trades occurring between $250.00 and $250.42.
Following the transaction, the reporting person beneficially owns 1,860 shares, held directly. This filing documents a planned disposition and provides price transparency across multiple trade executions on the reported date.
ACN: A shareholder filed a Form 144 notice to sell up to 6,902 Class A Ordinary shares, with an aggregate market value of $1,725,500. UBS Financial Services is listed as broker, and the approximate sale date is 10/22/2025 on the NYSE.
The shares were acquired via stock awards on 11/15/2024 (19), 02/14/2025 (8), and 10/20/2025 (6,875). Shares outstanding were 658,171,748; this is a baseline figure, not the amount being offered.
Accenture plc (ACN) filed a Form 144 notice for a proposed sale of 2,500 Class A ordinary shares, reflecting an aggregate market value of $621,525.00. The shares are slated for sale on 10/22/2025 through UBS Financial Services Inc. on the NYSE. The seller acquired these shares on 10/20/2025 via a stock award from the issuer. As context, 658,171,748 shares were outstanding.
Accenture plc (ACN) filed a Form 144 indicating a proposed sale of 9,000 Class A Ordinary shares through UBS Financial Services on the NYSE. The filing lists an aggregate market value of $2,246,165.10 for the shares and notes an approximate sale date of 10/22/2025.
The shares were acquired on 10/20/2025 via a stock award from the issuer. As context, 658,171,748 shares were outstanding at the time cited in the notice. A Form 144 is a notice of intent to sell restricted or control securities and does not by itself guarantee that a sale will occur.
FAQ
What is the current stock price of Accenture Plc Ireland (ACN)?
What is the market cap of Accenture Plc Ireland (ACN)?
